
IMAX CORP
IMAXNYSE๐ #1507 by market capEarnings Oct 21US Equity
$50.59โผ $0.61 (โ1.21%)
Market closed ยท at close1hโ
24hโผ 1.2%
7dโผ 0.1%
14dโฒ 3.9%
30dโฒ 31.8%
1yโฒ 97.5%
๐ฆMarket Cap
$2.77B
Small Cap
๐Revenue Growth (YoY)
+14.8%
Healthy
๐Gross Margin
59.6%
Healthy
๐ตFCF Margin
29.4%
Strong
โ๏ธP/S Ratio
6.7x
Fair
Otter Score
54
Weak
๐
Analyst Ratings
Price
$50.59
Total
25
Raised
1
Lowered
4
Avg PT
$49.57
H / L
$60 / $41
| Institution | Action | Rating | Date |
|---|---|---|---|
Rosenblatt | Reiterated | Buy | 2026-07-24 |
Roth Capital | Reiterated | Buy | 2026-07-24 |
B. Riley Securities | Reiterated | Buy | 2026-07-24 |
JP Morgan | Reiterated | Overweight | 2026-07-24 |
Wells Fargo | Reiterated | Equal Weight | 2026-07-24 |
Wedbush | Reiterated | Outperform | 2026-07-24 |
Barrington Research | Reiterated | Outperform | 2026-07-24 |
Macquarie | Reiterated | Outperform | 2026-07-08 |
Benchmark | Reiterated | Buy | 2026-05-22 |
Seaport Global | Reiterated | Buy | 2026-04-08 |
Goldman Sachs | Reiterated | Neutral | 2026-03-02 |
Roth MKM | Reiterated | Buy | 2024-10-31 |
MKM Partners | Reiterated | Buy | 2022-04-29 |
B. Riley FBR | Reiterated | Buy | 2020-03-18 |
Canaccord Genuity | Upgraded | Hold โ Buy | 2019-11-01 |
Piper Sandler | Downgraded | Overweight โ Neutral | 2018-01-10 |
PiperJaffray | Downgraded | Overweight โ Neutral | 2018-01-10 |
Credit Suisse | Reiterated | Neutral | 2017-09-28 |
Stifel Nicolaus | Reiterated | Buy | 2015-09-09 |
Stifel | Reiterated | Buy | 2015-09-09 |
Cormark Securities | Downgraded | Market Perform โ Reduce | 2013-10-03 |
Sterne Agee | Reiterated | Neutral | 2013-09-30 |
Susquehanna | Downgraded | Positive โ Neutral | 2012-10-17 |
National Alliance Securities | Reiterated | Market Perform | 2012-10-16 |
National Alliance | Reiterated | Market Perform | 2012-10-16 |
One row per institution, most recent rating